Vor Biopharma Inc - ESG Rating & Company Profile powered by AI
This page is a zero-cost Sustainability report covering Vor Biopharma Inc. This ESG score for Vor Biopharma Inc indicates its reporting of the United Nations Sustainable Development Goals. The report of Vor Biopharma Inc is prepared by All Street Sevva using proprietary AI.
Vor Biopharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.5; made up of an environmental score of 4.0, social score of 1.6 and governance score of 8.0.
4.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 852 | Vaccibody AS | 4.6 | High |
| 852 | argenx SE | 4.6 | High |
| 868 | Vor Biopharma Inc | 4.5 | High |
| 868 | CARsgen Therapeutics Holdings Ltd | 4.5 | High |
| 868 | Boiron SA | 4.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Vor Biopharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Vor Biopharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Vor Biopharma Inc report the average age of the workforce?
Sign up for free to unlockDoes Vor Biopharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Vor Biopharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Vor Biopharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Vor Biopharma Inc offer flexible work?
Sign up for free to unlockDoes Vor Biopharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Vor Biopharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Vor Biopharma Inc conduct supply chain audits?
Sign up for free to unlockDoes Vor Biopharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Vor Biopharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Vor Biopharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Vor Biopharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Vor Biopharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Vor Biopharma Inc disclose water use targets?
Sign up for free to unlockDoes Vor Biopharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Vor Biopharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes Vor Biopharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Vor Biopharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Vor Biopharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Vor Biopharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes Vor Biopharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Vor Biopharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Vor Biopharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Vor Biopharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Vor Biopharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Vor Biopharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Vor Biopharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Vor Biopharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Vor Biopharma Inc disclose its waste policy?
Sign up for free to unlockDoes Vor Biopharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes Vor Biopharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Vor Biopharma Inc disclose energy use targets?
Sign up for free to unlockDoes Vor Biopharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Vor Biopharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Vor Biopharma Inc
These potential risks are based on the size, segment and geographies of the company.
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.